Work Area: Patents

Pharma companies challenge GSK/Teva patent settlement

GlaxoSmithKline and Teva Pharmaceuticals conspired to delay generic competition for an epilepsy drug, a slew of direct purchasers including AmerisourceBergen and McKesson have argued.

06 February 2023

Experts defend DOJ’s patent pool blessing

A group of 25 former judges, government officials and professors are urging the Department of Justice to maintain the Trump Administration’s approval of the pooling of various 5G technologies.

05 December 2022

Judge blocks class certification against Takeda, Teva and others

A Pennsylvania federal judge has refused to certify a class of wholesale purchasers of a gout treatment medicine, finding that the claim against several major drugmakers is based on faulty expert testimony that does not hold up to rigorous analysis.

28 November 2022

Spain hits Merck with €39 million abuse fine for sham litigation

Spain’s antitrust watchdog has fined Merck €38.9 million for abusing its dominant position in the market for a type of contraceptive, finding the company unlawfully delayed the entry of a competing product through deceptive patent litigation.

25 October 2022

Cooperative Agreements: a Private Practitioner’s Perspective

Featured in The Guide to Life Sciences - First Edition

The covid-19 pandemic has been an opportunity for actors across the pharmaceutical supply chain to demonstrate the benefits that swift and flexible cooperation can bring to the industry.

21 October 2022

Experts urge DOJ to revoke Avanci 5G patent pool approval

The Department of Justice’s antitrust division was wrong to preemptively bless Avanci’s proposed patent pool for 5G cellular technology in vehicles, several competition experts have said.

19 October 2022

EU sends SO in first abusive drug patent filing case

The European Commission has sent a statement of objections to Teva Pharmaceuticals, alleging the company abused its dominance through unwarranted patent litigation and a misleading information campaign about a rival multiple sclerosis drug.

10 October 2022

IEEE recants controversial patent policies

A Wi-Fi standards-setting body has reversed several patent policies that licensors and antitrust officials in the Trump Administration derided as harmful to competition.

03 October 2022

Swiss enforcer raids Novartis over abusive patent litigation

Switzerland’s Competition Commission is working alongside the European Commission to investigate whether Novartis abused one of its patents by launching legal proceedings over a treatment to fight skin disease.

15 September 2022

UK issues first IP acquisition block over national security concerns

The UK government has blocked a Chinese technology company’s planned purchase of cutting-edge vision processing technology from the University of Manchester, marking the first time it has prohibited a deal under the country’s new foreign investment screening regime.

21 July 2022

Unlock unlimited access to all Global Competition Review content